22nd Century Conducts Three Short-Term Studies in Support of the Company’s MRTP Application to the FDA | Business Wire

22nd Century Conducts Three Short-Term Studies in Support of the Company’s MRTP Application to the FDA | Business Wire: 22nd Century Conducts Three Short-Term Studies in Support of the Company’s MRTP Application to the FDA; Details available at www.clinicaltrials.gov